Bed Bath & Beyond Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered director elections, auditor ratification, executive compensation, and amendments to the certificate of incorporation and equity plan, with all proposals approved. No questions were addressed during the Q&A.
-
Revenue grew 7% year-over-year with improved margins and a $24 million reduction in net loss. Integration of recent acquisitions and a unified data-driven platform are expected to drive further growth and $60 million in cost savings over the next nine months.
Fiscal Year 2025
-
2025 saw significant margin and EBITDA improvement despite revenue declines, driven by strategic SKU/vendor rationalization and cost discipline. 2026 targets low to mid-single-digit revenue growth, margin expansion, and profitability through integration of acquisitions and ecosystem synergies.
-
Q3 2025 saw a 93% improvement in net loss and 85% better adjusted EBITDA, with gross margin up 420 bps year-over-year. The company targets positive revenue growth and a 12% sales and marketing expense ratio in 2026, leveraging omnichannel expansion, AI, and operational efficiencies.
-
Q2 2025 revenue rose 22% sequentially to $282M, with gross margin up 360 bps year-over-year and adjusted EBITDA loss narrowing to $8M. The company is stabilizing core e-commerce, unlocking value from blockchain assets, and plans a CVR dividend for Medici Ventures portfolio proceeds.
-
The meeting covered board elections, auditor ratification, executive compensation, and amendments to the equity incentive plan. All directors were re-elected, auditor ratified, and executive pay approved, but the equity plan amendment failed due to quorum. No shareholder questions were raised.
-
Q1 2025 saw a 39% revenue decline due to restructuring, but gross margin improved to 25% and adjusted EBITDA loss narrowed by 72%. Management expects sequential revenue growth in Q2 and Q3, with ongoing investments in brand relaunches, omnichannel expansion, and blockchain initiatives.
-
Plans are underway to tokenize core assets like Bed Bath & Beyond and Buy Buy Baby, focusing on transparency, regulatory compliance, and shareholder value. The strategy aims to build a community of brand ambassadors, unlock asset value, and leverage tZERO as the primary platform, with future expansion into other assets and LifeChain initiatives.
Fiscal Year 2024
-
Q4 revenue declined 21% year-over-year, but gross margin improved to 23% and adjusted EBITDA loss narrowed by 43%. Management expects continued sequential margin and EBITDA improvements in 2025, with profitability prioritized over near-term revenue growth.
-
Q3 saw revenue decline but sequential margin and EBITDA improvement as the company prioritized profitability, reduced SG&A, and restructured its core brands. Strategic partnerships and asset monetization are expected to drive omni-channel growth and further margin gains in Q4 and beyond.
-
A new holding company model is being implemented, focusing on data and IP monetization, asset-light partnerships, and licensing deals to drive profitability. Overstock, Bed Bath & Beyond, and Zulily are managed as distinct brands, with new licensing and secured lending transactions set to expand brand presence and optimize inventory.
-
Q2 2024 saw sequential revenue and margin improvement, with a focus on profitability, cost reduction, and brand relaunches. Asset-light strategy, new partnerships, and a strong cash position support ongoing transformation, with profitability targeted for 2025.